The Significance of Remnant Cholesterol and Carotid Intima Media Thickness in Patients With MAFLD
NCT06449092 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 60
Last updated 2024-06-07
Summary
1. To detect the significance of remenant cholesterol in detection severity of MAFLD
2. To detect the significance of carotid intima-media thickness in MAFLD
Conditions
- Detect the Significance of Remnant Cholesterol in Detection Severity of MAFLD
Interventions
- DIAGNOSTIC_TEST
-
Lipid profile
carotid intima media thickness
Sponsors & Collaborators
-
Assiut University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-01-31
- Primary Completion
- 2026-01-31
- Completion
- 2026-01-31
Countries
- Egypt
Study Locations
More Related Trials
-
A Prospective Cohort Study of Metabolic Associated Fatty Liver Disease in China
NCT04573283 ·Status: RECRUITING
-
Serum Adiponectin as an Early Marker for Renal Impairment in Patients With Non-alcoholic Fatty Liver Disease.
NCT05106049 ·Status: UNKNOWN
-
Minerals Status in Relation to Overweight and Obese Adolescent
NCT06448858 ·Status: NOT_YET_RECRUITING
-
The Relation Between Adiposity, Inflammation, Glycaemia and Iron Absorption
NCT03310203 ·Status: COMPLETED ·Phase: NA
-
Chronic Hepatitis B Patients With Concurrent MAFLD: Cohort Study and Exercise Intervention.
NCT05956379 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Nonalcoholic Fatty Liver Disease in Morbidly Obese Patients
NCT04059029 ·Status: UNKNOWN
-
Deep Phenotyping of Peripheral Blood Cells and Circulating Factors in Metabolic Diseases
NCT06396871 ·Status: RECRUITING
-
Role of New Adipokines and Hepatokines in Prediction of Patients With Metabolic Syndrome or NAFLD
NCT02285218 ·Status: UNKNOWN
-
The Potential Value and Impact of Diagnostic Biomarkers for MAFLD Using Machine Learning Methods
NCT06061640 ·Status: UNKNOWN
-
A Community-based Prospective Cohort Study on Metabolic Dysfunction-Associated Fatty Liver Disease in Older Adults: From Metabolic Trajectories to Extrahepatic Outcomes
NCT07241195 ·Status: NOT_YET_RECRUITING
-
Characteristics of NAFLD Among Type 2 Diabetes Patients
NCT04999124 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Lipoprotein Metabolism in Normal Volunteers and Patients With Abnormal Levels of Lipoproteins
NCT00001226 ·Status: COMPLETED
-
Kinetics of Metabolic Cofactors in NAFLD
NCT03838822 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
A Prospective Cohort Study on Patient With Obesity Undergoing Weight Change
NCT07239167 ·Status: ENROLLING_BY_INVITATION
-
Dyslipidemia International Survey-China
NCT01732952 ·Status: UNKNOWN
-
Association Betweenq MAFLD ( Metabolic Associated Fatty Liver Disease) and Chronic Kidney Disease
NCT06135467 ·Status: NOT_YET_RECRUITING
-
RF Based QIMT & QAS Study on Chinese Adults
NCT04881292 ·Status: UNKNOWN
-
Body Weight and Vascular Function
NCT01675401 ·Status: COMPLETED ·Phase: NA
-
The Impact of Lower Limb Fractures on Body Mass Index (BMI)
NCT05162521 ·Status: UNKNOWN
-
Metabolic Subtypes of Non-Alcoholic Fatty Liver Disease
NCT05560997 ·Status: UNKNOWN
-
Testing for Increased Lipoproteins (a) [LP(a)] in Lymphedema Patients: Li-LY
NCT05962827 ·Status: RECRUITING ·Phase: NA
-
Study on MAFLD-related Cirrhosis Prevention and Treatment Strategies
NCT06135584 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
The Effect of Mild Weight Loss on Circulating Metabolite Profiles
NCT03135132 ·Status: COMPLETED ·Phase: NA
-
A Multi-center, Prospective, Observational Study to Describe the siTuation of Blood Lipid mAnagement Among the Population With hypeRtension and/or Type 2 diabeTes in Community Health Center
NCT05081440 ·Status: UNKNOWN
-
Detection of Pre-Diabetes in Overweight and Obese Children
NCT06117358 ·Status: NOT_YET_RECRUITING